Insider Transactions in Q3 2021 at Syneos Health, Inc. (SYNH)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2021
|
Donna Hildebrand Kralowetz EVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
248
-3.69%
|
$23,312
$94.3 P/Share
|
|
Sep 03
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,223
-15.19%
|
$876,185
$95.0 P/Share
|
|
Aug 03
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
35,553
-7.9%
|
$3,128,664
$88.16 P/Share
|
|
Aug 03
2021
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,553
+13.32%
|
$1,493,226
$42.76 P/Share
|
|
Aug 02
2021
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,710
-2.35%
|
$419,190
$89.9 P/Share
|
|
Jul 16
2021
|
Matthew E. Monaghan Director |
SELL
Open market or private sale
|
Direct |
170
-0.98%
|
$14,960
$88.64 P/Share
|
|
Jul 06
2021
|
Jason M. Meggs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
660
-0.54%
|
$59,400
$90.0 P/Share
|
|
Jul 06
2021
|
Jason M. Meggs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
660
+0.53%
|
$29,040
$44.58 P/Share
|